ConductScience.org, home

Paper41585259

Comparison of the efficacy of thalidomide combined with low-dose rituximab and low-dose rituximab alone in the treatment of steroid-resistant/refractory adult patients with primary immune thrombocytopenia: an open-label trial.

Yang S and 9 others. Front Med (Lausanne), 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Comparison of the efficacy of thalidomide combined with low-dose rituximab and low-dose rituximab alone in the treatment of steroid-resistant/refractory adult patients with primary immune thrombocytopenia: an open-label trial. Papers, record 41585259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41585259

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of the efficacy of thalidomide combined with low-dose rituximab and low-dose rituximab alone in the treatment of steroid-resistant/refractory adult patients with primary immune thrombocytopenia: an open-label trial.
PubMed
Journal
Front Med (Lausanne)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-28
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang SShuo
2Zhao MMingfeng
3Wang GGenjie
4Hu QQingzhu
5Tian YYing
6Yuan LLin
7Shen HHan
8Zhang JJunli
9Ji CChengfu
10Zhou HHua

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134660807The Efficacy and Safety of Different Dosages of Rituximab for Adults with Immune Thrombocytopenia: A Systematic Review and Meta-Analysis.Biomed Res Int2021https://conductscience.org/library/papers/34660807PubMed
234665865All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP.Blood2022https://conductscience.org/library/papers/34665865PubMed
322117897Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia.Curr Med Res Opin2012https://conductscience.org/library/papers/22117897PubMed
437081607Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months.Br J Haematol2023https://conductscience.org/library/papers/37081607PubMed
519399582Phase II and pharmacokinetic study of thalidomide in Japanese patients with relapsed/refractory multiple myeloma.Int J Hematol2009https://conductscience.org/library/papers/19399582PubMed
631866622
T-cell large granular lymphocytic (LGL) leukemia consists of CD4+/CD8dim and CD4-/CD8+ LGL populations in association with immune thrombocytopenia, autoimmune neutropenia, and monoclonal B-cell lymphocytosis.
J Clin Exp Hematop2019https://conductscience.org/library/papers/31866622PubMed
732071327Thalidomide Inhibits Human iPSC Mesendoderm Differentiation by Modulating CRBN-dependent Degradation of SALL4.Sci Rep2020https://conductscience.org/library/papers/32071327PubMed
833206273Thalidomide Inhibits Angiogenesis via Downregulation of VEGF and Angiopoietin-2 in Crohn's Disease.Inflammation2021https://conductscience.org/library/papers/33206273PubMed
924460857Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).Clin Exp Immunol2014https://conductscience.org/library/papers/24460857PubMed
1023926306Thalidomide corrects impaired mesenchymal stem cell function in inducing tolerogenic DCs in patients with immune thrombocytopenia.Blood2013https://conductscience.org/library/papers/23926306PubMed
1131770441Updated international consensus report on the investigation and management of primary immune thrombocytopenia.Blood Adv2019https://conductscience.org/library/papers/31770441PubMed
1230648105Efficacy and Safety of the Combination Treatment of Rituximab and Dexamethasone for Adults with Primary Immune Thrombocytopenia (ITP): A Meta-Analysis.Biomed Res Int2018https://conductscience.org/library/papers/30648105PubMed
1320546023Low-dose rituximab in adult patients with primary immune thrombocytopenia.Eur J Haematol2010https://conductscience.org/library/papers/20546023PubMed
1431884963CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells.J Neuroinflammation2019https://conductscience.org/library/papers/31884963PubMed
1532573072Antimetastatic effects of thalidomide by inducing the functional maturation of peripheral natural killer cells.Cancer Sci2020https://conductscience.org/library/papers/32573072PubMed
1640108021Addition of thalidomide for prevention of chemotherapy-induced nausea and vomiting in the second cycle after the failure of four-drug regimen in the first cycle.Med Oncol2025https://conductscience.org/library/papers/40108021PubMed
1715172781Thalidomide.Lancet2004https://conductscience.org/library/papers/15172781PubMed
1836966238Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis.Inflammopharmacology2023https://conductscience.org/library/papers/36966238PubMed
1931794604American Society of Hematology 2019 guidelines for immune thrombocytopenia.Blood Adv2019https://conductscience.org/library/papers/31794604PubMed
2021039469Natural killer cells in human autoimmune diseases.Immunology2010https://conductscience.org/library/papers/21039469PubMed

See all 29 referencesDownload CSV of references

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FCGR3A2214PubTator's text mininghttps://conductscience.org/library/genes/2214NCBI Gene
NCAM14684PubTator's text mininghttps://conductscience.org/library/genes/4684NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41585259

GET https://conductscience.org/api/papers/v1/41585259/references?page=2